Cediranib T2500
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Cediranib (AZD2171) is a highly potent (IC50 < 1 nmol/L) ATP-competitive inhibitor of recombinant KDR tyrosine kinase in vitro, also inhibits Flt1/4 (IC50: 5 nM/ᄇ3 nM), similar activity against PDGFR_ and c-Kit, selective more for VEGFR than PDGFR-_ (36-f
CAS nr:
288383-20-0
Purity:
98%
Molecular Weight:
450,51
SMILES:
Cc1cc2c([nH]1)ccc(c2F)Oc1ncnc2cc(c(cc12)OC)OCCCN1CCCC1
Formula:
C25H27FN4O3
Pathway:
Angiogenesis,Tyrosine Kinase/Adaptors,Angiogenesis,Tyrosine Kinase/Adaptors,Tyrosine Kinase/Adaptors,Angiogenesis,Autophagy,Tyrosine Kinase/Adaptors
Target:
PDGFR,PDGFR,FLT,FLT,VEGFR,VEGFR,Autophagy,c-Kit
